09:51 AM EST - Theralase Technologies Inc. : announced today that it has advanced its anti-cancer technology platform through an executed research agreement with Acadia University. Under the terms of the agreement, Acadia will supply initial quantities of Theralase's lead Photo Dynamic Compounds and the Standard Operating Procedures of how to synthesize them. Theralase Technologies Inc.
shares V.TLT are trading up $0.005 at $0.38.
